View this newsletter online
f t Forward to a friend
OphthalmologyWeb
Ophthalmology Newsletter
Featured Article     News     Featured Product     New Listings     Events     Video

learn more
Newsletter sponsor

POWERED FOR EFFICACY

Powerful clearance

  • More than twice as many patients achieved complete clearance of inflammation vs vehicle at Day 15 (46% vs 20%)1,2
Rapid resolution
  • PROLENSA® rapidly reduced inflammation vs placebo after cataract surgery2
    • Significant results were seen at Day 8 and Day 15 (P<0.0001)
    • Individual results may vary
Pain free at Day 1
  • Approximately 4 of 5 patients were pain free at Day 11,2 (78.8% vs 49.5% with vehicle, P<0.0001)
Available in a 3-mL bottle size

References: 1. PROLENSA® Prescribing Information. 2. Data on file, Bausch & Lomb Incorporated.

 
 
facebook » tweet this read more »
learn more
Featured article
top

Lumps, bumps, Tyndall effect, and contour abnormalities can occur after dermal fillers. Necrosis is another unwelcome event. But central retinal artery occlusion (CRAO) after dermal filler injections is the most devastating complication that has been reported several times after injections in multiple areas of the face, including the glabellar region, nose, nasolabial fold and temples.
   
 
facebook&raquo; tweet this read more »
learn more
Video
top

The Stellaris PC platform provides a high-performance, feature-rich, combined experience that leverages Bausch + Lomb’s legacy of vitreoretinal surgical innovation with the demonstrated excellence of the Stellaris phacoemulsification platform.
   
 
facebook&raquo; tweet this read more »
learn more
Featured product
top

The MASTERKA is indicated for congenital nasolacrimal duct obstructions that are resistant to probing. Unlike the ...
 
facebook&raquo; tweet this read more »
learn more
Featured event
top

This meeting provides intense, useful clinical information in an innovative and entertaining format.
 
facebook&raquo; tweet this read more »
Videos        Articles        Product Center        Drug Guide
Copyright© 2026 OphthalmologyWeb. All rights reserved.
This information is being brought to you because you
are a subscriber to OphthalmologyWeb. unsubscribe

OphthalmologyWeb

395 Oyster Point Blvd., Suite 321
South San Francisco, CA 94080